Larimar Therapeutics, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Larimar Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Larimar Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $80K, a 2.56% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Depreciation for 2023 was $311K, a 2.2% decline from 2022.
  • Larimar Therapeutics, Inc. annual Depreciation for 2022 was $318K, a 2.45% decline from 2021.
  • Larimar Therapeutics, Inc. annual Depreciation for 2021 was $326K, a 110% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $311K -$7K -2.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $318K -$8K -2.45% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $326K +$171K +110% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $155K +$77K +98.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $78K -$183K -70.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $261K +$73K +38.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $188K -$24K -11.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $212K +$142K +203% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $70K +$54K +338% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $16K +$4K +33.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $12K +$1K +9.09% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $11K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.